Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

76 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Insights into the expanding intestinal phenotypic spectrum of SOCS1 haploinsufficiency and therapeutic options.
Rodari MM, Cazals-Hatem D, Uzzan M, Martin Silva N, Khiat A, Ta MC, Lhermitte L, Touzart A, Hanein S, Rouillon C, Joly F, Elmorjani A, Steffann J, Cerf-Bensussan N, Parlato M, Charbit-Henrion F. Rodari MM, et al. Among authors: uzzan m. J Clin Immunol. 2023 Aug;43(6):1403-1413. doi: 10.1007/s10875-023-01495-7. Epub 2023 May 9. J Clin Immunol. 2023. PMID: 37156989 Free PMC article.
Janus kinase (JAK) inhibitor-induced acne in inflammatory bowel disease - an international, multicenter, retrospective cohort study.
Honap S, Temido MJ, Shakweh E, Badrulhisham F, Shields N, Mehta S, McBride J, Uzzan M, Lukáš M, Fumery M, Nogami A, Kobayashi T, Nancey S, Neves JC, Mendes JM, Wegener BA, Bergereau E, Fernandes R, Kuriakose Kuzhiyanjal AJ, Vieujean S, Spencer A, Baillie S, Estevinho MM, Simão I, O'Neill C, Gututui M, Thompson E, Jama A, Chai N, Pavlidis P, D'Amico F, Limdi J, Magro F, Sebastian S, Digby-Bell J, Parkes GC, Din S, Hart A, Peyrin-Biroulet L; JAKne International Study Group. Honap S, et al. Among authors: uzzan m. Clin Gastroenterol Hepatol. 2025 Jun 10:S1542-3565(25)00465-3. doi: 10.1016/j.cgh.2025.04.031. Online ahead of print. Clin Gastroenterol Hepatol. 2025. PMID: 40505791 Free article.
A series of Sickle cell disease-associated inflammatory bowel diseases: high prevalence of colonic involvement and primary sclerosing cholangitis.
Kirchgesner J, Augustin J, Bazin T, Freiha P, Nuzzo A, Seksik P, Sobhani I, Bartolucci P, Uzzan M. Kirchgesner J, et al. Among authors: uzzan m. Clin Res Hepatol Gastroenterol. 2025 May 23;49(7):102615. doi: 10.1016/j.clinre.2025.102615. Online ahead of print. Clin Res Hepatol Gastroenterol. 2025. PMID: 40414421 Free article.
Effectiveness and Safety of a Second JAK Inhibitor in Ulcerative Colitis: The J2J Multicentre Study.
Osty M, Altwegg R, Serrero M, Benezech A, Lecomte A, Cadiot G, Vuitton L, Wampach A, Nancey S, Buisson A, le Berre C, Rouillon C, Gilletta C, Goutorbe F, Fumery M, Hammoudi N, Caillo L, Vidon M, Arab N, Sickersen G, Cavicchi M, Vieujean S, Charkaoui M, Richard N, Wils P, Caron B, Amiot A, Nuzzo A, Laharie D, Kirchgesner J, Uzzan M; GETAID‐J2J group. Osty M, et al. Among authors: uzzan m. Aliment Pharmacol Ther. 2025 May 22. doi: 10.1111/apt.70199. Online ahead of print. Aliment Pharmacol Ther. 2025. PMID: 40400411
PErsistence and safety of subcutaneous infliximab 1 year after switch from intravenous route in IBD patients in REMission.
Mathieu N, Hupé M, Heluwaert F, Rivière P, Hébuterne X, Chupin A, Abitbol V, Bouguen G, Vuitton L, Gornet JM, Montuclard C, Nancey S, Cadiot G, Wils P, Gilletta C, de Maissin A, Altwegg R, Chanteloup E, Plastaras L, Ah Soune P, Bourreille A, Stefanescu C, Seksik P, Simon M, Uzzan M, Andrau P, Rouillon C, Arondel Y, Buisson A, Peyrin-Biroulet L, Mboup B, Vicaut E, Laharie D. Mathieu N, et al. Among authors: uzzan m. Clin Gastroenterol Hepatol. 2025 May 19:S1542-3565(25)00425-2. doi: 10.1016/j.cgh.2025.04.028. Online ahead of print. Clin Gastroenterol Hepatol. 2025. PMID: 40398832
Postoperative Outcomes in Tofacitinib-Treated Patients With Acute Severe Ulcerative Colitis Undergoing Colectomy.
Larson C, Berinstein JA, Tedesco N, Seidelin JB, Ovesen PD, Uzzan M, Amiot A, Nuzzo A, Laharie D, Constant BD, Albenberg L, El-Hussuna A, Bishu S, Cohen-Mekelburg S, Higgins PDR, Steenholdt C. Larson C, et al. Among authors: uzzan m. Clin Gastroenterol Hepatol. 2025 Apr 14:S1542-3565(25)00287-3. doi: 10.1016/j.cgh.2025.01.032. Online ahead of print. Clin Gastroenterol Hepatol. 2025. PMID: 40239733
Effectiveness and Safety of Upadacitinib Induction Therapy for 223 Patients With Crohn's Disease: A GETAID Multicentre Cohort Study.
Richard N, Amiot A, Seksik P, Altwegg R, Laharie D, Vuitton L, Nachury M, Bouguen G, Nancey S, Gilletta C, Rouilon C, Coffin B, Allez M, Buisson A, Le Berre C, Uzzan M, Caillo L, Pelletier AL, Peyrin-Biroulet L, Fumery M; GETAID. Richard N, et al. Among authors: uzzan m. Aliment Pharmacol Ther. 2025 May;61(10):1662-1670. doi: 10.1111/apt.70073. Epub 2025 Mar 4. Aliment Pharmacol Ther. 2025. PMID: 40038887 Free PMC article.
76 results